| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Suzuki Kentaro | Chief Marketing Officer | C/O NAUTILUS BIOTECHNOLOGY, INC., 2701 EASTLAKE AVE EAST, SEATTLE | /s/ Matthew Murphy, as Attorney-in-Fact | 10 Nov 2025 | 0002037191 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NAUT | Common Stock | Purchase | $5,960 | +4,000 | $1.49 | 4,000 | 06 Nov 2025 | Direct |